{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T18:15:54Z","timestamp":1780596954851,"version":"3.54.1"},"reference-count":7,"publisher":"Oxford University Press (OUP)","issue":"6","license":[{"start":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T00:00:00Z","timestamp":1736985600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/academic.oup.com\/pages\/standard-publication-reuse-rights"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,5,23]]},"abstract":"<jats:p>Epidermolysis bullosa (EB) is a rare inherited multisystem disorder. Colchicine is classified as an antigout and an anti-inflammatory drug. Currently, treatment options for EB are limited and focused on symptom management; there are no approved systemic treatments available. Here, we report three patients who were treated with colchicine to ameliorate EB wounds and systemic inflammation.<\/jats:p>","DOI":"10.1093\/ced\/llaf016","type":"journal-article","created":{"date-parts":[[2025,1,16]],"date-time":"2025-01-16T07:59:14Z","timestamp":1737014354000},"page":"1238-1240","source":"Crossref","is-referenced-by-count":1,"title":["Colchicine as a treatment option for inherited epidermolysis bullosa"],"prefix":"10.1093","volume":"50","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-7134-9726","authenticated-orcid":false,"given":"Sera","family":"Sarsam","sequence":"first","affiliation":[{"name":"Department of Dermatology, St George Hospital , Sydney, NSW ,","place":["Australia"]},{"name":"University of New South Wales , Sydney, NSW ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5279-782X","authenticated-orcid":false,"given":"Ben J","family":"Koszegi","sequence":"additional","affiliation":[{"name":"Department of Dermatology, St George Hospital , Sydney, NSW ,","place":["Australia"]},{"name":"University of New South Wales , Sydney, NSW ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2971-0199","authenticated-orcid":false,"given":"Dedee F","family":"Murrell","sequence":"additional","affiliation":[{"name":"Department of Dermatology, St George Hospital , Sydney, NSW ,","place":["Australia"]},{"name":"University of New South Wales , Sydney, NSW ,","place":["Australia"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,1,16]]},"reference":[{"key":"2025052303172637600_llaf016-B1","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMoa2206663","article-title":"Trial of beremagene geperpavec (B-VEC) for dystrophic epidermolysis bullosa","volume":"387","author":"Guide","year":"2022","journal-title":"N Engl J Med"},{"key":"2025052303172637600_llaf016-B2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1093\/bjd\/ljac001","article-title":"Efficacy and safety of Oleogel-S10 (birch triterpenes) for epidermolysis bullosa: results from the phase III randomized double-blind phase of the EASE study","volume":"188","author":"Kern","year":"2023","journal-title":"Br J Dermatol"},{"key":"2025052303172637600_llaf016-B3","doi-asserted-by":"crossref","first-page":"294","DOI":"10.3390\/pharmaceutics14020294","article-title":"Colchicine in managing skin conditions: a systematic review","volume":"14","author":"Dastoli","year":"2022","journal-title":"Pharmaceutics"},{"key":"2025052303172637600_llaf016-B4","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijwd.2016.04.001","article-title":"Colchicine may assist in reducing granulation tissue in junctional epidermolysis bullosa","volume":"2","author":"Kim","year":"2016","journal-title":"Int J Womens Dermatol"},{"key":"2025052303172637600_llaf016-B5","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jaad.2013.09.041","article-title":"Development, reliability, and validity of a novel Epidermolysis Bullosa Disease Activity and Scarring Index (EBDASI)","volume":"70","author":"Loh","year":"2014","journal-title":"J Am Acad Dermatol"},{"key":"2025052303172637600_llaf016-B6","doi-asserted-by":"crossref","first-page":"e1528","DOI":"10.1097\/MD.0000000000001528","article-title":"Proinflammatory cytokines and antiskin autoantibodies in patients with inherited epidermolysis bullosa","volume":"94","author":"Annicchiarico","journal-title":"Medicine (Baltimore)"},{"key":"2025052303172637600_llaf016-B7","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1111\/j.1600-0714.2009.00774.x","article-title":"Treatment with levamisole and colchicine can result in a significant reduction of IL-6, IL-8 or TNF-\u03b1 level in patients with mucocutaneous type of Behcet\u2019s disease","volume":"38","author":"Sun","year":"2009","journal-title":"J Oral Pathol Med"}],"container-title":["Clinical and Experimental Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ced\/advance-article-pdf\/doi\/10.1093\/ced\/llaf016\/61456478\/llaf016.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/50\/6\/1238\/61456478\/llaf016.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ced\/article-pdf\/50\/6\/1238\/61456478\/llaf016.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T07:17:34Z","timestamp":1747984654000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ced\/article\/50\/6\/1238\/7958166"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,1,16]]},"references-count":7,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2025,1,16]]},"published-print":{"date-parts":[[2025,5,23]]}},"URL":"https:\/\/doi.org\/10.1093\/ced\/llaf016","relation":{},"ISSN":["0307-6938","1365-2230"],"issn-type":[{"value":"0307-6938","type":"print"},{"value":"1365-2230","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2025,6]]},"published":{"date-parts":[[2025,1,16]]}}}